International Medical Vice President, Medical and Science, Insulin and Devices, Global Develoment
@
Novo Nordisk A/S
5 free lookups per month.
No credit card required.
Mari-Anne Gall's Location
Copenhagen, DK
Mari-Anne Gall's Work
International Medical Vice President, Medical and Science, Insulin and Devices, Global Develoment @ Novo Nordisk A/S
International Medical Vice President Medical and Science, Insulin, GH and Devices @ Novo Nordisk
International Medical Vice President, Medical and Science, Degludec. @ Novo Nordisk
Vice President, Medical and Science - Insulin Management, Global Development @ Novo Nordisk
Vice president, AERx Management, Global Development @ Novo Nordisk
Medical Director, Scientific Vice President, Global Development @ Novo Nordisk
Senior Principal Scientist, International Clinical Project Manager, Clinical Positioning @ Novo Nordisk
International Clinical Project Manager, Clinical Positioning @ Novo Nordisk
Medical Adviser, Analogues Launch Team, International Operations Marketing @ Novo Nordisk
Medical Adviser, Diabetes Care Strategic Marketing, Health Care International Operations @ Novo Nordisk
Mari-Anne Gall's Education
Board Company Danmark
Board Certificate
2021 - 2021
Københavns Universitet - University of Copenhagen
MD, DMSc
1976 - 1984
Mari-Anne Gall's Skills
Clinical Research
Clinical Development
Drug Development
Diabetes
Clinical Trials
Pharmaceutical Industry
Medicine
Healthcare
Endocrinology
Leadership
Mari-Anne Gall's Summary
Mari-Anne Gall, based in Copenhagen, DK, is currently a International Medical Vice President, Medical and Science, Insulin and Devices, Global Develoment at Novo Nordisk A/S, bringing experience from previous roles at Novo Nordisk. Mari-Anne Gall holds a 2021 - 2021 Board Certificate @ Board Company Danmark. With a robust skill set that includes Clinical Research, Clinical Development, Drug Development, Diabetes, Clinical Trials and more, Mari-Anne Gall contributes valuable insights to the industry. Mari-Anne Gall has 1 email and 1 mobile phone number on RocketReach.